441 724

Cited 2 times in

Cited 1 times in

The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

DC Field Value Language
dc.contributor.authorShin, Eui-Cheol-
dc.contributor.authorHan, Ji Won-
dc.contributor.authorKang, Wonseok-
dc.contributor.authorKato, Takanobu-
dc.contributor.authorKim, Seong-Jun-
dc.contributor.authorZhong, Jin-
dc.contributor.authorKim, Seungtaek-
dc.contributor.authorPark, Su-Hyung-
dc.contributor.authorSung, Pil Soo-
dc.contributor.authorWatashi, Koichi-
dc.contributor.authorPark, Jun Yong-
dc.contributor.authorWindisch, Marc P.-
dc.contributor.authorOh, Jong-Won-
dc.contributor.authorWakita, Takaji-
dc.contributor.authorHan, Kwang-Hyub-
dc.contributor.authorJang, Sung Key-
dc.date.accessioned2020-04-13T16:53:27Z-
dc.date.available2020-04-13T16:53:27Z-
dc.date.created2021-03-18-
dc.date.issued2020-03-
dc.identifier.issn1999-4915-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/175553-
dc.description.abstractHepatitis C virus (HCV) infects similar to 71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI-
dc.relation.isPartOfVIRUSES-BASEL-
dc.relation.isPartOfVIRUSES-BASEL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleThe Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorShin, Eui-Cheol-
dc.contributor.googleauthorHan, Ji Won-
dc.contributor.googleauthorKang, Wonseok-
dc.contributor.googleauthorKato, Takanobu-
dc.contributor.googleauthorKim, Seong-Jun-
dc.contributor.googleauthorZhong, Jin-
dc.contributor.googleauthorKim, Seungtaek-
dc.contributor.googleauthorPark, Su-Hyung-
dc.contributor.googleauthorSung, Pil Soo-
dc.contributor.googleauthorWatashi, Koichi-
dc.contributor.googleauthorPark, Jun Yong-
dc.contributor.googleauthorWindisch, Marc P.-
dc.contributor.googleauthorOh, Jong-Won-
dc.contributor.googleauthorWakita, Takaji-
dc.contributor.googleauthorHan, Kwang-Hyub-
dc.contributor.googleauthorJang, Sung Key-
dc.identifier.doi10.3390/v12030302-
dc.relation.journalcodeJ03792-
dc.identifier.eissn1999-4915-
dc.subject.keywordhepatitis C virus-
dc.subject.keywordantivirals-
dc.subject.keywordvaccine-
dc.subject.keywordflavivirus-
dc.subject.keywordliver diseases-
dc.contributor.alternativeNamePark, Jun Yong-
dc.contributor.affiliatedAuthorPark, Jun Yong-
dc.contributor.affiliatedAuthorHan, Kwang-Hyub-
dc.identifier.scopusid2-s2.0-85081904468-
dc.identifier.wosid000525486800043-
dc.citation.volume12-
dc.citation.number3-
dc.identifier.bibliographicCitationVIRUSES-BASEL, Vol.12(3), 2020-03-
dc.identifier.rimsid68401-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorhepatitis C virus-
dc.subject.keywordAuthorantivirals-
dc.subject.keywordAuthorvaccine-
dc.subject.keywordAuthorflavivirus-
dc.subject.keywordAuthorliver diseases-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryVirology-
dc.relation.journalResearchAreaVirology-
dc.identifier.articleno302-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.